The initiation of NLRP3 inflammasome in endothelial cells under pathophysiological conditions may exacerbate endothelial weakness, prompting hypertension, obesity, diabetes, neuroinflammation, retinopathy, atherosclerosis, cerebrovascular accident and malignancy. This evidence concerns the gene NLRP3 and diabetes mellitus.